Ticlopidine, a new antithrombotic drug: but is it better than aspirin for longterm use?
作者信息
Warlow C
机构信息
Department of Clinical Neurosciences, Western General Hospital, Edinburgh.
出版信息
J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):185-7. doi: 10.1136/jnnp.53.3.185.
Abstract
摘要
相似文献
1
Ticlopidine, a new antithrombotic drug: but is it better than aspirin for longterm use?噻氯匹定，一种新型抗血栓药物：但长期使用时它比阿司匹林更好吗？
J Neurol Neurosurg Psychiatry. 1990 Mar;53(3):185-7. doi: 10.1136/jnnp.53.3.185.
2
The role of antiplatelet therapy in stroke prevention.
Tenn Med. 1997 Nov;90(11):454-5.
3
Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.经皮球囊扩张式主动脉瓣置换术后抗栓治疗：阿司匹林与阿司匹林联合氯吡格雷的疗效对比（ARTE 研究）：一项随机临床试验。
JACC Cardiovasc Interv. 2017 Jul 10;10(13):1357-1365. doi: 10.1016/j.jcin.2017.04.014. Epub 2017 May 17.
4
Ticlopidine hydrochloride and prevention of stroke.盐酸噻氯匹定与中风预防
West J Med. 1993 Aug;159(2):182.
5
Aspirin for prevention of myocardial infarction and stroke.阿司匹林用于预防心肌梗死和中风。
Med Lett Drugs Ther. 1989 Aug 25;31(799):77-9.
6
Secondary prevention of stroke--new trials.中风的二级预防——新试验
Scott Med J. 1998 Feb;43(1):5-6. doi: 10.1177/003693309804300102.
7
Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study.间歇性跛行患者心肌梗死和中风的预防；噻氯匹定的作用。瑞典噻氯匹定多中心研究（STIMS）的结果。
J Intern Med. 1990 May;227(5):301-8. doi: 10.1111/j.1365-2796.1990.tb00164.x.
8
Lessons from MATCH for future randomised trials in secondary prevention of stroke.
Lancet. 2004;364(9431):305-7. doi: 10.1016/S0140-6736(04)16734-2.
9
[Cerebral secondary prevention--clopidogrel alone or in combination with ASS].[脑卒中介入治疗--氯吡格雷单药治疗或联合抗血小板治疗] （注：原文ASS可能有误，推测这里是抗血小板药物的意思，按推测翻译）
Internist (Berl). 2005 Nov;46(11):1278-82. doi: 10.1007/s00108-005-1507-5.
10
Cardiology update. Aspirin.心脏病学最新进展。阿司匹林。
Nurs Stand. 1994;8(49):52-3. doi: 10.7748/ns.8.49.52.s49.
引用本文的文献
1
Cost considerations in the pharmacological prevention and treatment of stroke.中风药物预防和治疗中的成本考量
Pharmacoeconomics. 1997 May;11(5):408-18. doi: 10.2165/00019053-199711050-00004.
2
Can the long term outcome of individual patients with transient ischaemic attacks be predicted accurately?短暂性脑缺血发作个体患者的长期预后能否被准确预测？
J Neurol Neurosurg Psychiatry. 1993 Jul;56(7):752-9. doi: 10.1136/jnnp.56.7.752.
3
Antiplatelet therapy--Part I.抗血小板治疗——第一部分。
West J Med. 1993 Apr;158(4):385-92.
4
Platelet aggregation inhibitors in neurology.
Pharm World Sci. 1993 Dec 17;15(6):243-51. doi: 10.1007/BF01871125.
5
Ticlopidine hydrochloride use and threatened stroke.盐酸噻氯匹定的使用与中风风险
West J Med. 1994 Jan;160(1):43-7.
6
Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?短暂性脑缺血发作：哪些患者发生严重血管事件的风险高（或低）？
J Neurol Neurosurg Psychiatry. 1992 Aug;55(8):640-52. doi: 10.1136/jnnp.55.8.640.
本文引用的文献
1
A comparison of risk factors and prognosis for transient ischemic attacks and minor ischemic strokes. The Oxfordshire Community Stroke Project.短暂性脑缺血发作和轻度缺血性卒中的危险因素及预后比较。牛津郡社区卒中项目。
Stroke. 1989 Nov;20(11):1494-9. doi: 10.1161/01.str.20.11.1494.
2
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group.一项比较盐酸噻氯匹定与阿司匹林预防高危患者中风的随机试验。噻氯匹定阿司匹林中风研究组。
N Engl J Med. 1989 Aug 24;321(8):501-7. doi: 10.1056/NEJM198908243210804.
3
XIIth congress of the International Society on Thrombosis and Haemostasis. Tokyo, Japan, 19-25 August 1989. Abstracts.
Thromb Haemost. 1989 Aug 19;62(1):1-647.
4
The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.
Lancet. 1989 Jun 3;1(8649):1215-20. doi: 10.1016/s0140-6736(89)92327-1.
Zotero 插件